DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis

Genes Dis. 2023 May 2;11(1):91-94. doi: 10.1016/j.gendis.2023.03.028. eCollection 2024 Jan.

Qiuxia Cui^{1

2

3}, Jian Sun^{3

4}, Jingping Yuan⁵, Juanjuan Li⁶, Chuanyu Yang³, Guangshi Du^{3

7}, Chengang Zhou³, Pu Qiu¹, Jidong Gao^{4

2}, Yuanqi Zhang¹, Dewei Jiang³, Ceshi Chen^{3

8

9}

¹ Affiliated Hospital of Guangdong Medical University Science & Technology of China, Zhanjiang, Guangdong 524000, China.
² Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong 518116, China.
³ Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China.
⁴ Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
⁵ Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
⁶ Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
⁷ Translational Medicine Research Center of Guizhou Medical University, Guiyang, Guizhou 550025, China.
⁸ Yunnan Cancer Hospital and the Third Affiliated Hospital of Kunming Medical University and Yunnan Cancer Center, Kunming, Yunnan 650500, China.
⁹ Academy of Biomedical Engineering, Kunming Medical University, Kunming, Yunnan 650500, China.

No abstract available